首页|25G玻璃体切除联合超声乳化手术中散光人工晶状体的应用

25G玻璃体切除联合超声乳化手术中散光人工晶状体的应用

扫码查看
目的 观察25G玻璃体切除联合超声乳化手术中植入环曲面人工晶状体(Toric intraocular lens,Toric IOL)的临床效果及稳定性。方法 回顾分析武汉市第一医院行白内障超声乳化吸出+Toric IOL植入患者58例(58眼),其中A组20例(20眼)为1期行25G玻璃体切除联合白内障超声乳化吸出+Toric IOL植入患者。B组18例(18眼)为25G玻璃体切除术后,2期行白内障超声乳化吸出+Toric IOL植入患者。C组20例(20眼)为单纯白内障超声乳化吸出+Toric IOL植入患者。术后随访6月。观察三组患者术前及术后视力、残余散光度、术后Toric IOL在眼内的旋转度、偏心量及像差。结果 术后6月,三组患者裸眼远视力(uncorrected distance visual acuity,UCVA)、最佳矫正视力(best corrected visual acuity,BCV A)均显著高于术前,差异有统计学意义(均P<0。05)。术后1周、1月、3月及6月,A组散光分别为(0。95±0。34)D、(1。01±0。34)D、(1。23±0。35)D、(1。21±0。32)D,B 组散光分别为(0。92±0。31)D、(1。14±0。33)D、(1。21±0。31)D、(1。22±0。33)D,均明显高于 C 组各时间点[(0。65±0。29)D、(0。73±0。24)D、(0。91±0。34)D、(0。96±0。37)D],差异有统计学意义(均P<0。05)。术后6月,A组IOL平均旋转(4。85±1。23)°,B组IOL平均旋转(4。78±1。56)°,显著高于C组[(3。80±1。20)°](均P<0。05),A组与B组间比较差异没有统计学意义。A组与B组全眼总像差、全眼总低阶像差(不包括离焦)、全眼总高阶像差差异没有统计学意义,但均高于C组,差异有统计学意义(均P<0。05)。A 组、B 组、C 组平均偏心量分别为(0。284±0。060)mm、(0。278±0。069)mm、(0。265±0。047)mm,差异无统计学意义(P>0。05)。结论 对于伴有角膜散光和玻璃体疾病的白内障患者,选择Toric IOL植入,能够实现较好的旋转稳定性,偏心程度小,从而获得更好的视觉质量。1期行玻璃体切除联合白内障手术与2期白内障手术比较,植入Toric IOL的稳定性没有明显差异。
Application of Toric Intraocular Lens in 25G Vitrectomy Combined with Phacoemulsification
Objective To observe the clinical effect and stability of implanting Toric intraocular lens(Toric IOL)during 25G vitrectomy combined with ultrasonic emulsification and aspiration of cataract.Methods A historical cohort study was conducted to analyze 58 patients(58 eyes)who underwent ultrasonic emulsification and aspiration of cataract+Toric IOL implantation in Wuhan No.1 Hospital.Among them,group A consisted of 20 cases(20 eyes)who underwent 25G vitrectomy combined with ul-trasonic emulsification and aspiration of cataract+primary Toric IOL implantation.group B included 18 cases(18 eyes)who un-derwent 25G vitrectomy followed by ultrasonic emulsification and aspiration of cataract+secondary Toric IOL implanta-tion.group C comprised 20 cases(20 eyes)who underwent ultrasonic emulsification and aspiration of cataract+Toric IOL im-plantation alone.Postoperative follow-up was conducted for 6 months to observe preoperative and postoperative visual acuity,re-sidual astigmatism,postoperative Toric IOL rotation,eccentricity,and aberrations.Results Six months after operation,the un-corrected distance visual acuity(UCVA)and best corrected visual acuity(BCVA)in all three groups were significantly higher than preoperative values(all P<0.05).At 1 week,1 month,3 months,and 6 months after operation,astigmatism results in group A were(0.95±0.34)D,(1.01±0.34)D,(1.23±0.35)D,(1.21±0.32)D,respectively.The results in group B were(0.92±0.31)D,(1.14±0.33)D,(1.21±0.31)D,(1.22±0.33)D,respectively,which were all significantly higher than those in group C at corresponding time points[(0.65±0.29)D,(0.73±0.24)D,(0.91±0.34)D,(0.96±0.37)D],with statistically significant differences(all P<0.05).At 6 months postoperatively,the mean IOL rotation was significantly higher in group A(4.85±1.23)° and group B(4.78±1.56)° compared to group C(3.80±1.20)°(both P<0.05).There was no statistically sig-nificant difference in rotation between group A and group B.The differences in total whole-eye aberrations,total whole-eye low-order aberrations(excluding defocus),and total whole-eye high-order aberrations were not statistically significant between group A and group B,but were all higher than those in group C(all P<0.05).The mean eccentricity of group A,group B,and group C were(0.284±0.060)mm,(0.278±0.069)mm,and(0.265±0.047)mm,respectively,with no statistically significant differ-ences(P>0.05).Conclusion For cataract patients with corneal astigmatism and vitreous disease,implanting Toric IOLs can a-chieve better rotational stability and lower eccentricity,resulting in improved visual quality.There was no significant difference in the stability of Toric IOL between primary IOL implantation combined with vitrectomy and secondary IOL implantation.

vitrectomyastigmatismintraocular lensphacoemulsificationrotational stability

冯劼、罗艳

展开 >

武汉市第一医院眼科,武汉 430022

玻璃体切除术 散光 人工晶状体 超声乳化 旋转稳定性

武汉市卫生计生委科研基金资助项目武汉市卫生计生委科研基金资助项目

WX15B18WX16C35

2024

华中科技大学学报(医学版)
华中科技大学

华中科技大学学报(医学版)

CSTPCD北大核心
影响因子:1.443
ISSN:1672-0741
年,卷(期):2024.53(4)